Know Cancer

or
forgot password

Phase 1 of Serum IGF II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer


N/A
18 Years
75 Years
Open (Enrolling by invite only)
Both
Cervical Cancer, Cervical Intraepithelial Neoplasia II, Cervical Intraepithelial Neoplasia III

Thank you

Trial Information

Phase 1 of Serum IGF II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer


Inclusion Criteria:



- Age 18 - 75 years

- Female

- Normal medical history

- Medical history of a single type of cancer confirmed by biopsy or equivalent criteria

- Squamous cell carcinoma of organs other than cervix

- Adenocarcinoma

- Medical history of inflammatory disease

- May be pregnant

- Pap smear positive for Cervical Intraepithelial Neoplasia II or III

- Squamous cell cervical cancer confirmed by biopsy

- Informed consent

- Willingness to submit a blood sample by venipuncture

- Willingness to submit a second blood sample if necessary

Exclusion Criteria:

- Age < 18 or > 75 years

- Medical history of cancer other than cervical cancer, Non-islet-cell tumor
hypoglycemia, Growth hormone deficiency, Acromegaly, Hepatoma, inflammatory disease
in addition to confirmed CIN and cervical cancer

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Authority:

United States: Institutional Review Board

Study ID:

onc11-03-164

NCT ID:

NCT01371695

Start Date:

May 2011

Completion Date:

September 2013

Related Keywords:

  • Cervical Cancer
  • Cervical Intraepithelial Neoplasia II
  • Cervical Intraepithelial Neoplasia III
  • IGF-II levels
  • Neoplasms
  • Uterine Cervical Neoplasms
  • Cervical Intraepithelial Neoplasia
  • Uterine Cervical Dysplasia
  • Carcinoma in Situ

Name

Location

Georgia Health SciencesAugusta, Georgia  30912